Granaticin B
N/A
Report date: 2026/03/28 20:00:32
NME
Base Information
Drug NameGranaticin B
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[4]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesColumbia University Medical CenterMemorial Sloan Kettering Cancer Center
China Registration ClassN/A
Develop Information
Active CompaniesLin BioScience Pty LtdLin Bioscience Inc
Inactive CompaniesMemorial Sloan Kettering Cancer CenterColumbia University Medical Center
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A